Global Atrial Fibrillation Surgery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

The Global Atrial Fibrillation Surgery Market is estimated to be USD 2.84 Bn in 2023 and is expected to reach USD 5.81 Bn by 2028 growing at a CAGR of 15.42%.

Market Dynamics

The major factors driving the growth of the global atrial fibrillation surgery market are the rise in the number of people suffering from atrial fibrillation conditions as well as an increase in health concerns caused by obesity, diabetes, and high alcohol use. Furthermore, the Increased demand for catheter ablation for cardiac arrhythmia therapy, as well as an increase in the rates of CVD and atrial fibrillation, are expected to boost the market growth. In addition, the rapid improvement in technology, increase in the number of atrial fibrillation surgical and catheter ablation procedures, increase in the applications from emerging economies are anticipated to offer significant growth opportunities for the market.

However, a scarcity of qualified and educated staff, as well as adverse preferences for pharmaceutical medicines over AF treatment devices, is restraining the atrial fibrillation surgery market's growth. In addition, high recurrence and complication rates are expected to create challenges for market growth.

Market Segmentation

• The Global Atrial Fibrillation Surgery Market is segmented further based on Product, Procedure, and Geography.
• By Product, the market is classified into catheter ablation products and surgical ablation products. Amongst the two, the catheter ablation product segment is estimated to hold the highest market share during the forecast period.
• By Procedure, the market is classified as catheter ablation procedures and surgical ablation procedures. Amongst the two, the catheter ablation procedures segment is estimated to hold the highest market share during the forecast period.
• By Geography, North America is projected to lead the market.

Recent Developments

1. Tempus announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG Analysis Platform. The platform, developed in collaboration with Geisinger, aids clinicians in identifying patients at increased risk of developing atrial fibrillation (AFib) or atrial flutter. - 24th March 2021
2. Medtronic received approval from Food and Drug Administration (FDA) for DiamondTemp Ablation (DTA) system, which treats patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy.. - 29th January 2021

Company Profiles

Some of the companies covered in this report are Abbott Laboratories, Advansta, Inc, Atricure, Inc, Biotronik SE & CO. KG, Boehringer Ingelheim GmbH, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Atrial Fibrillation Surgery Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market